Research Analysts Issue Forecasts for Organigram Q4 Earnings

Organigram Holdings Inc. (TSE:OGIFree Report) – Analysts at Alliance Global Partners lowered their Q4 2024 earnings estimates for shares of Organigram in a report released on Monday, December 9th. Alliance Global Partners analyst A. Grey now forecasts that the company will post earnings per share of ($0.03) for the quarter, down from their prior forecast of ($0.02). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Alliance Global Partners also issued estimates for Organigram’s Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at ($0.01) EPS and FY2025 earnings at ($0.03) EPS.

Separately, Canaccord Genuity Group cut their price objective on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a report on Monday.

Get Our Latest Stock Analysis on Organigram

Organigram Trading Down 0.5 %

Shares of OGI opened at C$2.16 on Wednesday. The stock’s fifty day simple moving average is C$2.29 and its 200 day simple moving average is C$2.31. Organigram has a twelve month low of C$1.61 and a twelve month high of C$3.95. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. The firm has a market capitalization of C$234.51 million, a P/E ratio of -0.86, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13.

Insiders Place Their Bets

In related news, Senior Officer Paolo De Luca sold 12,014 shares of Organigram stock in a transaction on Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total transaction of C$30,275.28. 31.32% of the stock is currently owned by insiders.

About Organigram

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Recommended Stories

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.